Study provides new evidence of synergistic effects of drugs that inhibit cell division and support for further clinical trials.
A new study from the University of Southern Denmark shows that football is a surprisingly efficient type of physical training for female prediabetes patients, with impressive effects on cardiovascular health after 16 weeks of training for 55-70-year old women with no prior football experience.
Interregional differences in somatic genetic landscape diversify prognosis in glioblastoma.
Scientists at Johns Hopkins have successfully created personalized digital replicas of the upper chambers of the heart and used them to guide the precise treatment of patients suffering from persistent irregular heartbeats. These simulations accurately identified where clinicians need to destroy tissue to restore the heart's normal rhythm.
New research published this week in JAMA Oncology has found a lack of racial and ethnic diversity in clinical trials for cancer drugs.
Countries that relax regulations for regenerative medicines, like stem cell 'treatments', could be causing a downward spiral in international standards.
A phase 1 clinical trial testing a new drug in pancreatic cancer had promising initial results, report researchers from the University of Michigan Rogel Cancer Center. The trial looked at AZD1775, an inhibitor designed to block an enzyme called Wee1, which plays a role in DNA damage repair.
Patients with metastatic colorectal cancer who engaged in moderate exercise while undergoing chemotherapy tended to have delayed progression of their disease and fewer severe side effects from treatment, according to the results of a new study.
A study published this week in the journal Pigment Cell & Melanoma Research has found that genes have a greater influence than previously thought not only on the number of moles you have but also where they are on your body.
A phase 1 clinical trial has demonstrated that a two-step gene therapy treatment was safe and effective in 31 patients with recurrent glioblastoma -- a stubborn form of brain cancer -- potentially overcoming a major hurdle that has hindered the use of systemically administered interleukin 12 (IL-12)-based regimens.